Wall Street Associates’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.53M Sell
92,701
-84,099
-48% -$1.43M 1.01% 21
2016
Q3
$3.24M Hold
176,800
1.1% 20
2016
Q2
$2.83M Buy
176,800
+57,124
+48% +$666K 1.13% 20
2016
Q1
$1.15M Hold
119,676
0.48% 85
2015
Q4
$2.15M Sell
119,676
-18,200
-13% -$336K 0.6% 49
2015
Q3
$3.07M Buy
+137,876
New +$3.72M 0.59% 54

Other funds holding TDOC

Wall Street Associates's TDOC Position: Q4 2016 in Review

Wall Street Associates reduced its Teladoc Health (TDOC) stake by 48% in Q4 2016, selling an estimated $1.43M and leaving 92,701 shares worth $1.53M. The position accounts for 1.01% of the portfolio, ranked #21.

Wall Street Associates first reported a position in TDOC in Q3 2015 and has held it in 6 quarters since. The position peaked at $3.24M in Q3 2016. 108 funds tracked by Wall St. Rank hold TDOC as of Q4 2016.

  • Wall Street Associates held 92,701 shares of Teladoc Health worth $1.53M as of Q4 2016.
  • Wall Street Associates sold 84,099 Teladoc Health shares in Q4 2016, an estimated $1.43M.
  • Teladoc Health made up 1.01% of Wall Street Associates's portfolio in Q4 2016, its #21 holding.
  • Wall Street Associates first reported a position in Teladoc Health in Q3 2015 and has held it in 6 quarters since.
  • Wall Street Associates's Teladoc Health position peaked at $3.24M in Q3 2016.
  • 108 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2016.

Based on Wall Street Associates's 13F filing for Q4 2016, filed 18 Jan 2017.